Safety of proton pump inhibitors

被引：11

作者：

Waldum, HL ^{[1
]}

Brenna, E ^{[1
]}

Martinsen, TC ^{[1
]}

机构：

[1] Univ Trondheim Hosp, Trondheim, Norway

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2000年 / 14卷 / 11期

关键词：

D O I：

10.1046/j.1365-2036.2000.00859.x

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

引用

页码：1537 / 1538

页数：2

共 11 条

[1] Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia [J].

Eissele, R ;

Brunner, G ;

Simon, B ;

Solcia, E ;

Arnold, R .

GASTROENTEROLOGY, 1997, 112 (03) :707-717

[2]

Hansen S, 1997, GASTROENTEROLOGY, V112, pA575

[3] ENTEROCHROMAFFIN-LIKE CELL CARCINOIDS OF GASTRIC-MUCOSA IN RATS AFTER LIFELONG INHIBITION OF GASTRIC-SECRETION [J].

HAVU, N .

DIGESTION, 1986, 35 :42-55

[4]

Laine L, 2000, ALIMENT PHARM THER, V14, P651

[5] CHANGES IN THE GASTRIC-MUCOSA OF THE MOUSE ASSOCIATED WITH LONG LASTING INSURMOUNTABLE HISTAMINE H-2 BLOCKADE [J].

POYNTER, D ;

SELWAY, SAM ;

PAPWORTH, SA ;

RICHES, SR .

GUT, 1986, 27 (11) :1338-1346

[6] EFFECT OF 7 YEARS DAILY ORAL-ADMINISTRATION OF OMEPRAZOLE TO BEAGLE DOGS [J].

SAFHOLM, C ;

HAVU, N ;

FORSSELL, H ;

SUNDELL, G ;

MATTSSON, H .

DIGESTION, 1994, 55 (03) :139-147

[7]

WALDUM HL, 1991, EUR J GASTROEN HEPAT, V3, P245

[8]

Waldum HL, 2000, ALIMENT PHARM THERAP, V14, P15

[9]

Waldum HL, 1998, CANCER, V83, P435, DOI 10.1002/(SICI)1097-0142(19980801)83:3<435::AID-CNCR11>3.3.CO

[10]

2-9

← 1 2 →